Baker Bros. Advisors »

Aeglea Biotherapeutics shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $17M 1.0M 16.76
2025-06-30 $9.4M 627k 14.97